The common multifocal nature of hepatocellular carcinoma (HCC) makes it one of the best candidates for targeted drugs and high expression of glypican-3 (GPC3) in HCC makes NIR-PIT a very appealing treatment strategy for this tumour. Here, GPC3 is linked to neoplasm.